Director Declaration

By

Regulatory News | 28 Jul, 2021

Updated : 10:00

RNS Number : 7506G
Investec PLC
28 July 2021
 

Investec Limited

Incorporated in the Republic of South Africa

Registration number 1925/002833/06      

JSE share code: INL

NSX share code: IVD

BSE share code: INVESTEC

ISIN: ZAE000081949

LEI: 213800CU7SM6O4UWOZ70

Investec plc

Incorporated in England and Wales

Registration number 3633621

LSE share code: INVP

JSE share code: INP

ISIN: GB00B17BBQ50

LEI: 2138007Z3U5GWDN3MY22


 

As part of the dual listed company structure, Investec plc and Investec Limited (together the "Investec Group") notify both the London Stock Exchange and the JSE Limited of matters which are required to be disclosed under the Disclosure Guidance and Transparency Rules, and Listing Rules of the Financial Conduct Authority (the "FCA") and/or the JSE Listings Requirements.

 

Accordingly we advise of the following:

 

Director Declaration

 

In accordance with Listing Rule 9.6.14R, the Investec Group announces that Fani Titi, Chief Executive of the Investec Group, will not stand for re-election at the Annual General Meetings ("AGMs") of Ninety One plc and Ninety One Limited (together "Ninety One"), and will accordingly step down as a non-executive director from the Ninety One Board on 04 August 2021.

 

Pursuant to the relationship agreement entered into with Ninety One, Khumo Shuenyane, an independent non-executive director of the Investec Group, has been selected to succeed Fani as the Investec Group representative on the Ninety One Board. Khumo will accordingly be appointed a non-executive director of Ninety One with effect from 01 August 2021.

 

In accordance with Listing Rule 9.6.14R, the Investec Group further announces that Zarina Bassa, Senior Independent Director of the Investec Group, will be appointed as non-executive director of Mediclinic International plc with effect from 01 February 2022.

 

London and Johannesburg

28 July 2021

 

Sponsor:

Investec Bank Limited

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNDKFBNFBKKBOB

Last news